Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01369108 · ClinicalTrials.gov registry record · NA

Clinical Study on a New Flowable Composite as a Restorative in Adult Teeth

A NA study of Dental Caries, sponsored by Solventum US.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT01369108 is a NA study of Dental Caries that has completed, run by Solventum US. The registered enrollment target is 60 participants, below the 720-participant average among 30 other Dental Caries trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01369108, a NA study of Dental Caries, has completed, sponsored by Solventum US.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Study hypothesis: a new, low polymerization stress flowable composite performs no differently to a conventional, highly filled composite filling material when used as a restorative in small cavities in back teeth. Study will evaluate the clinical performance of a low shrinking flowable composite filling material, compared with a conventional, highly filled composite restorative when used to permanently fill small cavities in molar and premolar teeth in adult patients.

Conditions Studied

Interventions

  • DEVICE Flowable composite
  • DEVICE Conventional composite restorative

Study Locations (1)

Alabama

  • University of Alabama at Birmingham School of Dentistry, 605 School of Dentistry Building, 1919 7th Avenue South - Birmingham

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2011-01
Est. Completion 2013-12
Phase NA

Sponsor

Solventum US

41 total trials

What the Registry Record Tells You About NCT01369108

The ClinicalTrials.gov registry entry for NCT01369108 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 720-participant average among 30 other Dental Caries trials with a reported enrollment target (92% lower). The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dental Caries appearing as the primary indexed condition, and to 2 interventions - of which Flowable composite is the first listed.

NCT01369108 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT01369108 about?

NCT01369108 is a clinical study titled "Clinical Study on a New Flowable Composite as a Restorative in Adult Teeth". Study hypothesis: a new, low polymerization stress flowable composite performs no differently to a conventional, highly filled composite filling material when used as a restorative in small cavities in back teeth. Study will evaluate the clinical performance of a low shrinking flowable composite fi...

What is the current status of trial NCT01369108?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2011-01. Estimated completion is 2013-12.

What conditions does trial NCT01369108 study?

This clinical trial studies the following conditions: Dental Caries.

What interventions are being tested in trial NCT01369108?

The interventions under investigation include: Flowable composite (DEVICE), Conventional composite restorative (DEVICE).

Who is sponsoring clinical trial NCT01369108?

This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01369108 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dental Caries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.